首页> 外文期刊>Peptides: An International Journal >Identification and characterization of binding sites for human urotensin-II in Sprague-Dawley rat renal medulla using quantitative receptor autoradiography.
【24h】

Identification and characterization of binding sites for human urotensin-II in Sprague-Dawley rat renal medulla using quantitative receptor autoradiography.

机译:使用定量受体放射自显影技术鉴定和鉴定Sprague-Dawley大鼠肾髓质中人尿素-II的结合位点。

获取原文
获取原文并翻译 | 示例
       

摘要

Urotensin-II (U-II), a ligand for the G-protein-coupled receptor UT, has been characterized as the most potent mammalian vasoconstrictor identified to date. Although circulating levels of U-II are altered in lower species (e.g., fish) upon exposure to hypo-osmotic stress, little is known about the actions of this cyclic undecapeptide within the kidney, an organ that plays a pivotal role in the control of cardiovascular homeostasis, influencing both cardiac preload (plasma volume) and after load (peripheral resistance). The present study reports the identification of specific, high affinity [125I]hU-II binding sites in Sprague-Dawley rat kidney outer medulla by autoradiography and also through membrane radioligand binding (Kd 1.9 +/- 0.9 nM and Bmax 408 +/- 47 amol mm(-2) and Kd 1.4 +/- 0.3 nM and Bmax 51.3 +/- 7.8 fmol mg(-1) protein, respectively). Differences were observed in the binding characteristics within rat strains. Compared to the Sprague-Dawley, Wistar Kyoto (WKY) and spontaneously hypertensive (SHR) rat kidney outer medulla displayed low density < 20 fmol mg(-1) protein and low affinity (> 1 microM) [125I]hU-II binding sites. Thus, the relative contribution of specific U-II binding sites to the physiological actions of U-II in the control of cardiorenal homeostasis is worthy of further investigation.
机译:Urotensin-II(U-II)是G蛋白偶联受体UT的配体,已被表征为迄今为止确定的最有效的哺乳动物血管收缩剂。尽管暴露于低渗胁迫下较低物种(例如鱼)中的U-II循环水平发生了变化,但人们对这种环状十一肽在肾脏中的控制作用知之甚少,而肾脏在控制肾脏中起着关键作用。心血管稳态,影响心脏预负荷(血浆容量)和负荷后(外周阻力)。本研究报告了通过放射自显影以及膜放射性配体结合(Kd 1.9 +/- 0.9 nM和Bmax 408 +/- 47 amol mm(-2)和Kd 1.4 +/- 0.3 nM和Bmax 51.3 +/- 7.8 fmol mg(-1)蛋白)。在大鼠品系中观察到结合特性的差异。与Sprague-Dawley相比,Wistar Kyoto(WKY)和自发性高血压(SHR)大鼠肾脏外延髓表现出低密度<20 fmol mg(-1)蛋白和低亲和力(> 1 microM)[125I] hU-II结合位点。因此,特定的U-II结合位点对控制心肾稳态的U-II生理作用的相对贡献值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号